G
Giuseppe Mancia
Researcher at University of Milano-Bicocca
Publications - 1465
Citations - 152794
Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Massimo Volpe,Giuliano Tocci,Sebastiano Sciarretta,Paolo Verdecchia,Bruno Trimarco,Giuseppe Mancia +5 more
TL;DR: It is indicated that the risk of MI is comparable with use of ARBs and other antihypertensive drugs in a wide range of clinical conditions.
Journal ArticleDOI
Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height2.7
Cesare Cuspidi,Valentina Giudici,Francesca Negri,Stefano Meani,Carla Sala,Alberto Zanchetti,Giuseppe Mancia +6 more
TL;DR: The data indicate that a consistent portion of essential hypertensive patients are positive for LVH by the criterion of LVM indexed to height2.7, but not to BSA; this population is characterized by an unhealthy metabolic profile as well as by the presence of extracardiac organ damage.
Journal ArticleDOI
Clinical significance of "white coat" hypertension.
Giuseppe Mancia,G Parati +1 more
TL;DR: This issue of Hypertension includes a report by Julius and colleagues on a topic of great importance for the diagnosis of hypertension, that is, the alerting reaction and blood pressure rise triggered by blood pressure measurements and commonly referred to as the "white coat" phenomenon.
Journal ArticleDOI
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.
Gianfranco Parati,Enrico Agabiti-Rosei,George L. Bakris,Grzegorz Bilo,Giovanna Branzi,Franco Cecchi,Marzena Chrostowska,Alejandro de la Sierra,Mónica Doménech,Maria Dorobantu,Thays Faria,Yong Huo,Bojan Jelaković,Thomas Kahan,Alexandra Konradi,Stéphane Laurent,Nanfang Li,Kushal Madan,Giuseppe Mancia,Richard J McManus,Pietro Amedeo Modesti,Juan Eugenio Ochoa,José A. Octavio,Stefano Omboni,Paolo Palatini,Jeong Bae Park,Dario Pellegrini,Sabine Perl,Cristian Podoleanu,Giacomo Pucci,Josep Redon,Nicolas Federico Renna,Moo Yong Rhee,Enrique Rodilla Sala,Ramiro A. Sanchez,Roland E. Schmieder,Davide Soranna,George S. Stergiou,Milos Stojanovic,Konstantinos Tsioufis,Maria Grazia Valsecchi,Franco Veglio,Gabriel Waisman,Ji-Guang Wang,Paulina Wijnmaalen,Antonella Zambon,Alberto Zanchetti,Yuqing Zhang +47 more
TL;DR: The effects of MUCH management strategy based on ABPM or on OBPM on CV and renal intermediate outcomes (changing left ventricular mass and microalbuminuria, coprimary outcomes) at 1 year and on CV events at 4 years and on changes in BP-related variables will be assessed.
Journal ArticleDOI
European Society of Hypertension position paper on renal denervation 2018
Roland E. Schmieder,Felix Mahfoud,Michel Azizi,Atul Pathak,Kyriakos Dimitriadis,Abraham A. Kroon,Christian Ott,Filippo Scalise,Giuseppe Mancia,Costas Tsioufis +9 more
TL;DR: The heterogeneity of the blood pressure-lowering response point to the clinical need to identify predictors for efficacy, and questions on long-term safety could not have been answered due to the short duration of the sham-controlled randomized clinical trials.